SEATTLE GENETICS (SGEN) Covered Calls

SEATTLE GENETICS covered calls Seattle Genetics, Inc. is a biotechnology company, which is focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.

You can sell covered calls on SEATTLE GENETICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SGEN (prices last updated Fri 4:16 PM ET):

SEATTLE GENETICS (SGEN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
74.64 +0.43 73.75 80.00 445K - 12B
Covered Calls For SEATTLE GENETICS (SGEN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 75 2.85 77.15 -2.8% -28.4%
Dec 21 75 6.90 73.10 2.6% 7.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Seattle Genetics, Inc. is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer. Its product ADCETRIS or brentuximab vedotin has been approved by both U.S. Food and Drug Association and Health Canada in U.S. and Canada respectively. ADCETRIS is an antibody-drug conjugate comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.